A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H
10.1210/jc.2013-3713
Saved in:
Main Authors: | Bible, K.C., Suman, V.J., Molina, J.R., Smallridge, R.C., Maples, W.J., Menefee, M.E., Rubin, J., Karlin, N., Sideras, K., Morris III, J.C., McIver, B., Hay, I., Fatourechi, V., Burton, J.K., Webster, K.P., Bieber, C., Traynor, A.M., Flynn, P.J., Goh, B.C., Isham, C.R., Harris, P., Erlichman, C. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/127089 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study
by: Bible, K.C., et al.
Published: (2016) -
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer
by: Bible, K.C., et al.
Published: (2016) -
Medullary carcinoma of the thyroid presenting as fatal asphyxia
by: Aw, T.C., et al.
Published: (2014) -
Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer
by: Iau, P.T.C., et al.
Published: (2014) -
Medullary gnathostomiasis in a white patient: use of immunodiagnosis and magnetic resonance imaging
by: J. Chandenier, et al.
Published: (2018)